Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
European Journal of Haematology|May 25, 2010
Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1Kenneth I Ataga, Julia E Brittain, Dominic Moore, et al.Journal of Neuroscience Research|September 18, 2016
Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe's disease: Present convictions and future prospectsPeirong Hu, Yedda Li, Nana Nikolaishvili-Feinberg, et al.International Journal of Cancer|June 13, 2009
FAK overexpression and p53 mutations are highly correlated in human breast cancerVita M Golubovskaya, Kathleen Conway-Dorsey, Sharon N Edmiston, et al.Transplantation and Cellular Therapy|November 21, 2022
Correlation of Engraftment and Time from Melphalan Administration to Stem Cell InfusionKaci Shuman, Shannon Palmer, Brandi Anders, et al.Journal of Pain and Symptom Management|June 6, 2026
Impact of Specialized Pediatric Palliative Care on Bereaved Parents' Mental and Physical HealthClaudia Delgado-Corcoran, Huong D Meeks, Sarah E Wawrzynski, et al.Cancer Investigation|October 6, 2005
A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancerHeidi H Gillenwater, Jeannine S McCune, Celeste Lindley, et al.Eclinicalmedicine|December 3, 2025
Rituximab is associated with an increased risk of malaria among adult lymphoma patients in Malawi: a prospective observational cohortLuke Eastburg, Sneha Ashish Makhijani, Catherine Suzanne Forconi, et al.Cancer Cell|May 18, 2004
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expressionChristine H Chung, Joel S Parker, Gamze Karaca, et al.Blood Cancer Discovery|November 15, 2021
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid LeukemiaJoshua F Zeidner, Benjamin G Vincent, Anastasia Ivanova, et al.Pageof 4